Vida Health, a digital therapeutics company, has raised USD 28.5 million in a funding round led by General Atlantic, Ally Bridge, Canvas Ventures, and Hercules Capital, with participation from other investors. This brings the total funds raised by the company to USD 216.5 million.
The company also announced that its founder and chief executive officer (CEO), Stephanie Tilenius, will step down after nine years of service and has appointed Joe Murad as the new CEO. Tilenius will transition to an advisory role, while Murad has joined the company's board of directors.
The new funds will be used to scale up the company’s operations and pursue growth prospects, especially in the GLP-1 industry.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.